Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedCap ABOSTO:MCAP +3.27%95 EV-to-OCF is 22.40 as of Aug. 31, 2026, which is 3% below its 10-year median of 23.15. GuruFocus rates OSTO:MCAP with a GF Score™ of 95/100 and a GF Value™ of kr572.85 (Fairly Valued). The stock has 1 warning sign investors should review. Among 851 Medical Devices & Instruments companies, MedCap AB ranks worse than 77.91% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, MedCap AB's Enterprise Value is kr8,687 Mil.
MedCap AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was kr388 Mil. Therefore, MedCap AB's EV-to-OCF for today is 22.40.
The historical rank and industry rank for MedCap AB's EV-to-OCF or its related term are showing as below:
OSTO:MCAP'
s EV-to-OCF Range Over the Past 10 Years
Min: -27.14 Med: 23.15 Max: 58.63
Current: 22.4
During the past 13 years, the highest EV-to-OCF of MedCap AB was 58.63. The lowest was -27.14. And the median was 23.15.
OSTO:MCAP's EV-to-OCF is ranked worse than 77.91% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 7.91
vs OSTO:MCAP: 22.40
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
MedCap AB's share price for today is kr568.50.
MedCap AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr16.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
MedCap AB EV-to-OCF Related Terms
MedCap AB EV-to-OCF Historical Data
* Premium members only.
The historical data trend for MedCap AB's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, MedCap AB's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedCap AB EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, MedCap AB's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where MedCap AB's EV-to-OCF falls into.
MedCap AB's current Enterprise Value is kr8,687 Mil.
MedCap AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr388 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedCap AB (OSTO:MCAP) has a EV-to-OCF of 22.40 as of Aug. 31, 2026. This is near median its historical median of 23.15. According to the industry distribution chart, MedCap AB ranks #663 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 77.9%.
Is MedCap AB's EV-to-OCF too high?
MedCap AB's current EV-to-OCF of 22.40 is near median its 10-year median of 23.15. The Medical Devices & Instruments industry median EV-to-OCF is 7.91. MedCap AB's value of 22.40 is 183.2% above this industry median. Based on the distribution chart, MedCap AB ranks #663 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, MedCap AB has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MedCap AB's EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MedCap AB ranks #663 out of 851 companies for EV-to-OCF. This places MedCap AB in the lower half of its industry. The industry median EV-to-OCF is 7.91. MedCap AB's value of 22.40 is 183.2% above this benchmark. While the company's 10-year median is 23.15 vs. the industry median of 7.91, MedCap AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.91, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedCap AB's current EV-to-OCF of 22.40 is 183.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedCap AB's current EV-to-OCF is 22.40, which is near median its own 10-year median of 23.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedCap AB stock overvalued right now?
Based on GuruFocus' analysis, MedCap AB (OSTO:MCAP) is currently considered Fairly Valued. The stock's GF Value™ is kr572.85, compared to a current price of kr568.50 — trading 0.8% below its estimated fair value. The current EV-to-OCF is 22.40, which is near median its 10-year median of 23.15 and 183.2% above the Medical Devices & Instruments industry median of 7.91. MedCap AB's overall GF Score™ is 95/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For MedCap AB (OSTO:MCAP), the current EV-to-OCF is 22.40 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MedCap AB (OSTO:MCAP) Overvalued in 2026?
Based on GuruFocus' analysis, MedCap AB stock appears to be undervalued.
The current stock price of kr568.50 is trading 0.8% below its estimated GF Value™ of kr572.85.
GuruFocus considers MedCap AB to be Fairly Valued.
Key valuation signals for OSTO:MCAP:
EV-to-OCF: 22.40 (near median its 10-year median of 23.15)
GF Value™: kr572.85 vs. price of kr568.50 (0.8% below fair value)
Industry Position: 183.2% above the Medical Devices & Instruments median (#663 of 851)
No single metric tells the full story. See the OSTO:MCAP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MedCap AB acquires and develops profitable, market-leading niche companies in the Nordic life science industry. It is diversified into two business areas namely Medical technology and Specialist medicines. Medical Technology mainly develops and sells various medical technology products and services. Its Specialist medicines develop and sell medicines within the regulatory classes of registered, extemporaneous and licensed medicines.
95GF Score
Get the complete analysis for OSTO:MCAP
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:MCAP has been successfully added to your 
